Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.10 and traded as high as $0.18. Enzon Pharmaceuticals shares last traded at $0.18, with a volume of 11,112 shares trading hands.
Enzon Pharmaceuticals Stock Performance
The business has a 50-day moving average of $0.12 and a 200-day moving average of $0.10.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Further Reading
- Five stocks we like better than Enzon Pharmaceuticals
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Where to Find Earnings Call Transcripts
- MarketBeat Week in Review – 6/24 – 6/28
- Stock Dividend Cuts Happen Are You Ready?
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
